Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Trial Profile

Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Semaglutide (Primary) ; Dulaglutide
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms PIONEER 10
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 20 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 27 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 11 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top